X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
USA (Orange Book)
Europe
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
73
PharmaCompass offers a list of Levoleucovorin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Levoleucovorin manufacturer or Levoleucovorin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Levoleucovorin manufacturer or Levoleucovorin supplier.
PharmaCompass also assists you with knowing the Levoleucovorin API Price utilized in the formulation of products. Levoleucovorin API Price is not always fixed or binding as the Levoleucovorin Price is obtained through a variety of data sources. The Levoleucovorin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A AM013621 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of AM013621, including repackagers and relabelers. The FDA regulates AM013621 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. AM013621 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of AM013621 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A AM013621 supplier is an individual or a company that provides AM013621 active pharmaceutical ingredient (API) or AM013621 finished formulations upon request. The AM013621 suppliers may include AM013621 API manufacturers, exporters, distributors and traders.
click here to find a list of AM013621 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A AM013621 DMF (Drug Master File) is a document detailing the whole manufacturing process of AM013621 active pharmaceutical ingredient (API) in detail. Different forms of AM013621 DMFs exist exist since differing nations have different regulations, such as AM013621 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A AM013621 DMF submitted to regulatory agencies in the US is known as a USDMF. AM013621 USDMF includes data on AM013621's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The AM013621 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of AM013621 suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing AM013621 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for AM013621 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture AM013621 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain AM013621 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a AM013621 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of AM013621 suppliers with NDC on PharmaCompass.
AM013621 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of AM013621 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right AM013621 GMP manufacturer or AM013621 GMP API supplier for your needs.
A AM013621 CoA (Certificate of Analysis) is a formal document that attests to AM013621's compliance with AM013621 specifications and serves as a tool for batch-level quality control.
AM013621 CoA mostly includes findings from lab analyses of a specific batch. For each AM013621 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
AM013621 may be tested according to a variety of international standards, such as European Pharmacopoeia (AM013621 EP), AM013621 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (AM013621 USP).
Market Place
